(Q53852903)

21 May 2018

review article

1 reference

reason for deprecated rank

title

Paraoxonasa, ¿algo más que una enzima? (Spanish)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

reason for deprecated rank

28 March 2024

Paraoxonase, something more than an enzyme? (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599410

28 March 2024

author name string

Amaia Canales

1

1 reference

21 May 2018

Francisco J. Sánchez-Muniz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599410

28 March 2024

language of work or name

Spanish

0 references

publication date

1 October 2003

1 reference

21 May 2018

25 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14599410

full work available at URL

28 March 2024

https://api.elsevier.com/content/article/PII:S0025775303740111?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

https://api.elsevier.com/content/article/PII:S0025775303740111?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

28 March 2024

1 reference

21 May 2018

volume

121

1 reference

21 May 2018

issue

14

1 reference

21 May 2018

page(s)

537-548

1 reference

21 May 2018

Cardiovascular effects of carbon monoxide and cigarette smoking

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Effects of age and cigarette smoking on serum concentrations of lipids and apolipoproteins in a male military population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Fibrinogen--the key to familial CHD or just another shadow in Plato's allegory?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Role of oxidised low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Review of progress in sterol oxidations: 1987-1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Lipoprotein profiles and serum peroxide levels of aged women consuming palmolein or oleic acid-rich sunflower oil diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Circulating levels of endothelial function are modulated by dietary monounsaturated fat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Dietary fat saturation affects apolipoprotein AII levels and HDL composition in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Dietary fat modulates serum paraoxonase 1 activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Structural organization of the human PON1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The genetic mapping and gene structure of mouse paraoxonase/arylesterase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Isolation and complete covalent structure of liver microsomal paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Male and female cord blood lipoprotein profile differences throughout the term-period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Apolipoprotein A-II, HDL metabolism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Cholinesterase, arylesterase, and lipoprotein parameters in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Apolipoprotein J is associated with paraoxonase in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Clusterin: physiologic and pathophysiologic considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

7 January 2021

Human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Dietary determinants of serum paraoxonase activity in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Vitamin C and E intake is associated with increased paraoxonase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974011-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Genetic polymorphism and interethnic variability of plasma paroxonase activity

63

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

Comparison of purified human and rabbit serum paraoxonases

28 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities

28 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions

28 March 2024

89

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

28 March 2024

93

1 reference

https://api.crossref.org/works/10.1016/S0025-7753(03)74011-1

28 March 2024

Identifiers

1 reference

21 May 2018

release_rhrb5x4pgngb3ckrblx4ge7tvi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rhrb5x4pgngb3ckrblx4ge7tvi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

21 May 2018